Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Must currently be diagnosed with either Type I or Type II diabetes mellitus.~* Must currently be performing self monitoring of blood glucose~* Must be between 18-70 years of age (inclusive).~* Must be able to read and follow study instructions in English.~Exclusion Criteria:~* Pregnant (self reported)~* History of poor blood circulation.~* Any skin condition on his or her fingers that prevents blood sampling.~* History of a bleeding disorder.~* Neuropathy or other condition affecting sensation in the hands.~* Self-reported blood borne infection (e.g., HIV, hepatitis B or C \[non A, non B\], syphilis, malaria, babesiosis, brucellosis, leptospirosis, arboviral infections, relapsing fever, T lymphotropic virus Type 1, Creutzfeldt-Jakob disease).~* Currently participating in another study~* Employed by BD, J\&J, Roche or the Clinical Site.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Arm A (Type: OTHER): In Visit 1 subjects tested BD/33G, OTM/33G, and OTM/28G devices. In Visit 2 subjects tested BD/33G and OTM/28G. See purpose for additional information.
- Arm B (Type: OTHER): In Visit 1 subjects tested BD/33G, OTM/33G and OTU/28G devices. In Visit 2 subjects tested BD/33G and OTU/28G. See purpose for additional information.
- Arm C (Type: OTHER): In Visit 1 subjects tested BD/33G, OTM/33G and ACC/28G devices. In Visit 2 subjects tested BD/33G and ACC/28G. See purpose for additional information.
- Arm D (Type: OTHER): In Visit 1 subjects tested BD/33G, OTM/33G and OTM/28G devices. In Visit 2 subjects tested OTM/33G and OTM/28G. See purpose for additional information.

Based on this trial design, predict the completion outcome and termination type (if applicable).